Issue Deep Dive
Canada / Global Health
Last updated: May 31, 2023
ODA in Context
Canada was the sixth-largest OECD DAC donor to global health in 2021. Canada was first among DAC donors in terms of its prioritization of global health; ODA to this sector represented 31% percent of its total ODA spending.
Funding for COVID-19 control spiked in 2021, taking up 61% of total bilateral health ODA. Basic nutrition also increased between 2020 and 2021, by 43%, in line with Canada’s priorities for its COVID-19 response.
Other highly funded sectors within global health in 2021 included reproductive health care as well as population policy and administrative management. Reproductive health care saw a marginal 1% decrease, while population policy and administrative management grew by 40%. Most health sectors saw an increase in bilateral ODA in 2021, given the increased prioritization of health in the wake of the COVID-19 pandemic.
Multilateral Spending and Commitments
Canada is a strong supporter of health multilaterals, especially in recent years, given their importance to the global COVID-19 response.
In May 2020, Canada joined the ACT-A. Canada’s funding for ACT-A has been channeled through CEPI, Global Fund, Gavi, FIND, Unitaid, UNICEF, WHO, and PAHO.
More recent pledges to multilateral organizations are summarized in the second slide below.
Funding and Policy Outlook
Health will remain a cornerstone of Canada’s FIAP: Within health, Canada’s emphasis will remain on the health of women and girls, particularly related to SRHR and MNCH. Canada has been a vocal supporter of these issues through its participation in Women Deliver, She Decides, Family Planning 2020, the Ouagadougou Partnership, and the PMNCH.
Canada will likely continue to champion SRHR, especially given the threat posed by COVID-19: In 2020, the Canadian government joined leaders from 58 other countries in calling out the importance of safeguarding SRHR during the COVID-19 crisis. In 2020, Canada was the 5th-largest provider of overall contributions to the UNFPA. The focus of this funding has been SRHR in conflict zones, health system strengthening, and midwifery projects.
The end of Roe v. Wade?
|Global health R&D is also important to addressing many of the global health challenges that disproportionately affect the world’s most disadvantaged people. For more information on how donor countries are supporting global health R&D across three main areas — 1) EIDs; 2) PRNDs; and 3) SRH — read the excellent G-Finder reports and explore the interactive data portal created by Policy Cures Research. Not all funding mentioned in these analyses qualifies as ODA.|
Looking for a cross donor perspective?
Learn more about SEEK's work on global health
Explore other deep-dives
Read more on Global Health